ACAD
19.36
-0.93
-4.58%
AEMD
4.9
-1.1
-18.33%
APRI
1.17
-0.03
-2.50%
ARNA
1.57
-0.04
-2.48%
ATEC
0.4
+0.01
+1.32%
CNAT
1.84
-0.01
-0.54%
CRXM
0.25
0.00
0.00%
CYTX
0.179
-0.011
-5.6345%
DXCM
61.98
-8.65
-12.25%
GNMK
5.08
-0.42
-7.64%
HALO
7.9
-0.37
-4.47%
ILMN
136.05
-7.33
-5.11%
INNV
0.038
-0.002
-5.2500%
INO
6.01
-0.25
-3.99%
ISCO
2.4
+0.13
+5.73%
ISIS
57.56
0.00
0.00%
LGND
92.5
-6.44
-6.51%
LPTN
0.16
-0.015
-8.5143%
MBVX
0.54
-0.02
-3.55%
MEIP
1.24
0.00
0.00%
MNOV
4.15
-0.14
-3.26%
MRTX
20.26
-1.1
-5.15%
MSTX
0.41
+0.01
+2.4506%
NBIX
35.99
-1.08
-2.91%
NUVA
41.45
-2.98
-6.71%
ONCS
1.69
-0.01
-0.59%
ONVO
2.09
-0.21
-9.13%
OREX
1.84
-0.05
-2.65%
OTIC
13.8
-0.25
-1.78%
QDEL
16.4
-0.49
-2.90%
RCPT
231.96
0.00
0.00%
RGLS
5.94
-0.41
-6.46%
RMD
57.42
-0.4
-0.69%
SCIE
0.001
0.00
+11.111%
SPHS
1.68
-0.09
-5.08%
SRNE
5.05
+0.04
+0.80%
TROV
3.85
-0.13
-3.27%
VICL
0.333
-0.007
-1.9741%
VOLC
18
0.00
0.00%
ZGNX
8.49
-0.41
-4.61%
ACAD
19.36
-0.93
-4.58%
AEMD
4.9
-1.1
-18.33%
APRI
1.17
-0.03
-2.50%
ARNA
1.57
-0.04
-2.48%
ATEC
0.4
+0.01
+1.32%
CNAT
1.84
-0.01
-0.54%
CRXM
0.25
0.00
0.00%
CYTX
0.179
-0.011
-5.6345%
DXCM
61.98
-8.65
-12.25%
GNMK
5.08
-0.42
-7.64%
HALO
7.9
-0.37
-4.47%
ILMN
136.05
-7.33
-5.11%
INNV
0.038
-0.002
-5.2500%
INO
6.01
-0.25
-3.99%
ISCO
2.4
+0.13
+5.73%
ISIS
57.56
0.00
0.00%
LGND
92.5
-6.44
-6.51%
LPTN
0.16
-0.015
-8.5143%
MBVX
0.54
-0.02
-3.55%
MEIP
1.24
0.00
0.00%
MNOV
4.15
-0.14
-3.26%
MRTX
20.26
-1.1
-5.15%
MSTX
0.41
+0.01
+2.4506%
NBIX
35.99
-1.08
-2.91%
NUVA
41.45
-2.98
-6.71%
ONCS
1.69
-0.01
-0.59%
ONVO
2.09
-0.21
-9.13%
OREX
1.84
-0.05
-2.65%
OTIC
13.8
-0.25
-1.78%
QDEL
16.4
-0.49
-2.90%
RCPT
231.96
0.00
0.00%
RGLS
5.94
-0.41
-6.46%
RMD
57.42
-0.4
-0.69%
SCIE
0.001
0.00
+11.111%
SPHS
1.68
-0.09
-5.08%
SRNE
5.05
+0.04
+0.80%
TROV
3.85
-0.13
-3.27%
VICL
0.333
-0.007
-1.9741%
VOLC
18
0.00
0.00%
ZGNX
8.49
-0.41
-4.61%
Home » Archive by Category

Xconomy

West Coast Bio Roundup: Shkreli, T4 Diabetes, Cella-Done, A16Z+Bio

November 20, 2015 – 5:42 am

So much for lying low. Investors led by Martin Shkreli have bought a majority of the shares of failed South San Francisco, CA-based KaloBios Pharmaceuticals, which has been in dire straits for some…

[[Click headline to continue reading.]]

Salk Recruits Nobel Laureate Liz Blackburn as First Woman President

November 19, 2015 – 1:08 pm

The Salk Institute has named Elizabeth Blackburn, a Nobel laureate and UC San Francisco professor of biochemistry and biophysics, as its first woman president. Blackburn has been a non-resident…

[[Click headline to continue reading.]]

Waving White Flag, Celladon Merges With Rare Disease Co. Eiger Bio

November 19, 2015 – 6:35 am

A slew of companies have gone public amidst gene therapy’s recent renaissance, and technological advances have gotten these types of treatments closer than they’ve ever been to impacting healthcare…

[[Click headline to continue reading.]]

Keeping Score, Clinical Watchdogs Push Drugmakers For More Open Data

November 17, 2015 – 4:30 am

Should drug companies publicly release all data from the tests they conduct on human volunteers? A growing number of parties say yes, and last week, a group of academics unveiled a scorecard to…

[[Click headline to continue reading.]]

Stealth Co Unveiling, New Speakers Added to Nov. 17 Healthcare Event

November 13, 2015 – 4:29 pm

Two great new speakers—one of whom will bring a major new company out of stealth mode—have just joined the lineup for Tuesday’s Healthcare Summit 2015. If you were on the fence before, you should get…

[[Click headline to continue reading.]]

Stealth Co Unveiling, New Speakers Added to Nov. 17 Healthcare Event

November 13, 2015 – 4:29 pm

Two great new speakers—one of whom will bring a major new company out of stealth mode—have just joined the lineup for Tuesday’s Healthcare Summit 2015. If you were on the fence before, you should get…

[[Click headline to continue reading.]]

Advancing Drugs at Roche, Sophiris, Coherus, and Other Bio News

November 13, 2015 – 12:53 pm

An economic impact report released this week by the California Life Sciences Association found that life sciences companies in the Golden State currently have 1,235 new drugs in the development…

[[Click headline to continue reading.]]

Advancing Drugs at Roche, Sophiris, Coherus, and Other Bio News

November 13, 2015 – 12:53 pm

An economic impact report released this week by the California Life Sciences Association found that life sciences companies in the Golden State currently have 1,235 new drugs in the development…

[[Click headline to continue reading.]]

Amplyx Raises $40.5M to Advance Drug for Deadly Fungal Infections

November 11, 2015 – 1:02 am

Sometime after the Irish drug giant Shire acquired San Diego-based Lumena Pharmaceuticals last year, Lumena CEO Mike Grey went back to work on a new startup—but he wouldn’t say too much about…

[[Click headline to continue reading.]]

Amplyx Raises $40.5M to Advance Drug for Deadly Fungal Infections

November 11, 2015 – 1:02 am

Sometime after the Irish drug giant Shire acquired San Diego-based Lumena Pharmaceuticals last year, Lumena CEO Mike Grey went back to work on a new startup—but he wouldn’t say too much about…

[[Click headline to continue reading.]]